OPK stock news · OPKO Health, Inc.
Get alerts for OPK
Follow OPKO Health, Inc. (OPK) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for OPKOPKO Health, Inc. has agreed to sell its BioReference Health assets for $722 million.
NeutralOPKO agreed to sell some testing assets for cash, with more possible from 4Kscore sales. The cash and the business being sold leave its outlook unclear.
Crude oil prices go up, while Charles Schwab's stock drops after its third-quarter report.
NeutralLabcorp agreed to buy selected BioReference Health assets for $722 million in cash, plus a possible $150 million extra payment. OPKO would receive cash but give up those assets, and the story does not say how the sale changes the business overall.
OPKO Health is selling its testing businesses to Labcorp in a big deal worth up to $872 million.
Good for OPKOPKO gives up its testing businesses, but receives $722 million at closing and may receive up to $150 million more. The sale frees resources for its biopharmaceutical work, making the shift favorable.
12 health care stocks are changing a lot before the market opens on Thursday.
NeutralOPKO Health shares rose in pre-market trading. The roundup gives no company update explaining the move, so it does not change the business outlook.
OPKO Health, Inc. says its bondholders can now convert their notes into stock.
NeutralOPKO made about $121 million of notes convertible through Dec. 31, with payment in shares. That may spread ownership across more shares but also removes debt, so the filing points both ways.